-
-
-
-
-
-
-
Lilly to buy Merida Biosciences for up to $2.875 billion
-
-
-
-
-
-
-
Earnings preview: Bernstein sees ‘clear potential for further upside’ in this stock
-
-
-
-
-
-
-
This digital health stock is ready to re-rate higher: Goldman
-
-
-
-
-
-
-
Lilly's Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Lowered to $$1,058 at Leerink Partners
-
-
-
-
-
-
-
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
-
-
-
-
-
-
-
Eli Lilly to acquire Orna Therapeutics for up to $2.4 billion
-
1,233,828 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


